Skip to main content
. 2017 Jun 13;2017:bcr2016218889. doi: 10.1136/bcr-2016-218889

Figure 1.

Figure 1

PET/CT images at various stages during the presentation. In A and B, PET/CT demonstrates a FDG avid mediastinal mass; C and D show an MIP image on PET/CT demonstrating an increase in the size of the mediastinal mass; E and F showing a decreased FDG uptake in the mediastinum and appearance of new FDG avid metastasis in the liver on PET/CT. FDG, 18-fluorodeoxyglucose; MIP, maximal intensity projection; PET, positron emission tomography.